- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05945251
ICBT for Children With FAPDs - the Child's Pain Regulation
Individualized Online Cognitive Behavioral Therapy for Children With Functional Abdominal Pain Disorders - the Child's Pain Regulation
Functional abdominal pain disorders (FAPDs) in children are common (14%) and abdominal pain has increased rapidly in children during the last ten years in Sweden. Many children with FAPDs have low quality of life, missed school days, and about 30-40% suffer from psychiatric comorbidity. FAPDs are often sustained into adulthood and a large Swedish cohort study showed that abdominal pain during childhood is an independent strong predictor anxiety and depression later in life. Internet-cognitive behavioral therapy (Internet-CBT) can improve FAPD symptoms, but a significant number of children does not respond to the treatment.
We will here determine the pain regulation in children with FAPDs, compared with healthy controls, and assess:
What aspects of the child's pain regulation is related to improvement for children with FAPDs engaging in Internet-CBT?
Does some aspects of the child's pain regulation change during treatment?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Maria Lalouni, PhD
- Phone Number: +46709473148
- Email: maria.lalouni@ki.se
Study Contact Backup
- Name: Viktor Vadenmark, MSc
- Phone Number: +46707220594
- Email: viktor.vadenmarklundqvist@ki.se
Study Locations
-
-
Karolinska Institutet
-
Stockholm, Karolinska Institutet, Sweden, 17177
- Recruiting
- Karolinska Institutet
-
Contact:
- Maria Lalouni, PhD
- Phone Number: +46709473148
- Email: maria.lalouni@ki.se
-
Contact:
- Viktor Vadenmark, MSc
- Phone Number: +707220594
- Email: viktor.vadenmark.lundqvist@ki.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Children 8-17 years with FAPDs: Have been offered treatment at BUP Internetbehandling for FAPDs.
Children 8-17 years without FAPDs: Not affected by recurrent (every week) or persistant pain during the last year.
Exclusion Criteria:
Contraindication for MR (metal implant or metal object in body, claustrophobia, pregnancy)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
FAPDs
Children 8-17 years with FAPDs
|
Ten weekly modules for children and ten weekly modules for parents.
Exposure-based cognitive behavioral therapy delivered online with asynchronous support via text messages from psychologists.
|
Controls
Children 8-17 years without FAPDs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pressure pain threshold on navel
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Algometer pressure (in kPa) for the pain threshold
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Unpleasantness of pressure pain threshold on navel
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Children rate their unpleasantness on a scale 0-10
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pressure pain threshold on thigh
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Algometer pressure (in kPa) for the pain threshold
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Unpleasantness of pressure pain threshold on thigh
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Children rate their unpleasantness on a scale 0-10
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Conditioned pain modulation
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Conditioned pain: hand in 10°C cold water, test pain: presseure pain thresholds by algometer on the participant's thigh.
Difference in pressure pain thresholds with and without the simultaneous conditioned stimuli
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Temporal summation
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Pinprick stimuli of low pain, one time, then repeated 10 times.
Pain after repeated stimulus minus pain for the single stimulus.
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Sensory attenuation of pain
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Pressure pain thresholds (kPa) applied by the child or the experimenter.
Sensory attenuation = difference in pain threshold between self-induced and experimenter induced
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Resting state fMRI
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
fMRI during low pain compared with non-painful tactile stimulus
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Pediatric Quality of Life Inventory Gastrointestinal Symptom Scale (PedsQL Gastro)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Self-assessed questionnaire of abdominal symptoms
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Faces Pain Rating Scale (FACES)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Self-assessed questionnaire of pain intensity
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Visceral sensitivity Index, child-adapted short version (VSI-C)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Self-assessed questionnaire of gastrointestinal-specific anxiety
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Irritable bowel syndrome-behavioral responses questionnaire, child-adapted short version (BRQ-C)
Time Frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Self-assessed questionnaire of gastrointestinal-specific avoidance and controlling behaviors
|
Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maria Lalouni, PhD, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20223238
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Abdominal Pain Syndrome
-
Baylor College of MedicineUniversity of WashingtonRecruitingIrritable Bowel Syndrome | Functional Abdominal Pain | Functional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Functional Bowel Disorder | Functional Abdominal Pain DisordersUnited States
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Abdominal Pain (AP)
-
Aarhus University HospitalKarolinska InstitutetRecruitingIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeDenmark
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentActive, not recruitingIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeNetherlands
-
Medical College of WisconsinCompletedDyspepsia | Irritable Bowel Syndrome | Functional Gastrointestinal Disorders | Functional Abdominal Pain SyndromeUnited States
-
Michigan State UniversitySpectrum Health HospitalsWithdrawnFunctional Abdominal Pain SyndromeUnited States
-
University Hospital TuebingenSymbioPharm GmbHUnknownIrritable Bowel Syndrome | Functional Abdominal Pain SyndromeGermany
-
University of Warmia and MazuryNational Science Centre, PolandCompletedFunctional Abdominal Pain SyndromePoland
-
Assiut UniversityUnknownFunctional Abdominal Pain Syndrome
-
Universidad de ColimaRecruitingFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Irritable Bowel Syndrome Variant of ChildhoodMexico
Clinical Trials on Internet-delivered cognitive behavioral therapy
-
Karolinska InstitutetRecruitingDepression | Anxiety Disorders | Insomnia | Psychiatric DisorderSweden
-
Uppsala UniversityUppsala University HospitalCompletedChronic Pain | Stress, Psychological | Anxiety | Depressive SymptomsSweden
-
Karolinska InstitutetCompletedObsessive-Compulsive DisorderSweden
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmActive, not recruiting
-
Karolinska InstitutetRegion StockholmCompleted
-
Region SkaneLund UniversityActive, not recruiting
-
University of AarhusUniversity of Southern DenmarkCompletedAnxiety DisordersDenmark
-
Megan PetrovTerminatedInsomnia Chronic | Subclinical Disease and/or SyndromeUnited States
-
University of PittsburghCompletedDepression | Anxiety | Sickle Cell DiseaseUnited States
-
Vilnius UniversityActive, not recruitingSleep | Tinnitus | Depression, Anxiety | Distress, EmotionalLithuania